These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15331126)

  • 1. Correlation between sICAM-1 and depressive symptoms during adjuvant treatment of melanoma with interferon-alpha.
    Schaefer M; Horn M; Schmidt F; Schmid-Wendtner MH; Volkenandt M; Ackenheil M; Mueller N; Schwarz MJ
    Brain Behav Immun; 2004 Nov; 18(6):555-62. PubMed ID: 15331126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma: results from the multicenter DeCOG trial.
    Heinze S; Egberts F; Rötzer S; Volkenandt M; Tilgen W; Linse R; Boettjer J; Vogt T; Spieth K; Eigentler T; Brockmeyer NH; Hinzpeter A; Hauschild A; Schaefer M
    J Immunother; 2010 Jan; 33(1):106-14. PubMed ID: 19952950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy.
    Capuron L; Ravaud A; Miller AH; Dantzer R
    Brain Behav Immun; 2004 May; 18(3):205-13. PubMed ID: 15050647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rIFN-beta-1b on serum circulating ICAM-1 in relapsing remitting multiple sclerosis and on the membrane-bound ICAM-1 expression on brain microvascular endothelial cells.
    Trojano M; Defazio G; Avolio C; Paolicelli D; Giuliani F; Giorelli M; Livrea P
    J Neurovirol; 2000 May; 6 Suppl 2():S47-51. PubMed ID: 10871785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma.
    Friebe A; Horn M; Schmidt F; Janssen G; Schmid-Wendtner MH; Volkenandt M; Hauschild A; Goldsmith CH; Schaefer M
    Psychosomatics; 2010; 51(6):466-73. PubMed ID: 21051677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment levels of sTNF-R1 and sIL-6R are associated with a higher vulnerability for IFN-alpha-induced depressive symptoms in patients with malignant melanoma.
    Friebe A; Schwarz MJ; Schmid-Wendtner M; Volkenandt M; Schmidt F; Horn M; Janssen G; Schaefer M
    J Immunother; 2007 Apr; 30(3):333-7. PubMed ID: 17414324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B; Portalès P; Thanh AD; Merlet S; Dereure O; Clot J; Corbeau P
    Br J Dermatol; 2005 Apr; 152(4):690-6. PubMed ID: 15840100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hypertriglyceridemia in patients receiving interferon for malignant melanoma.
    Wong SF; Jakowatz JG; Taheri R
    Ann Pharmacother; 2004 Oct; 38(10):1655-9. PubMed ID: 15304625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.
    Bouwhuis MG; Suciu S; Collette S; Aamdal S; Kruit WH; Bastholt L; Stierner U; Salès F; Patel P; Punt CJ; Hernberg M; Spatz A; ten Hagen TL; Hansson J; Eggermont AM;
    J Natl Cancer Inst; 2009 Jun; 101(12):869-77. PubMed ID: 19509353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major depression and risk of depressive symptomatology associated with short-term and low-dose interferon-alpha treatment.
    Beratis S; Katrivanou A; Georgiou S; Monastirli A; Pasmatzi E; Gourzis P; Tsambaos D
    J Psychosom Res; 2005 Jan; 58(1):15-8. PubMed ID: 15771865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
    Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
    Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-efficacy for coping with cancer in melanoma patients: its association with physical fatigue and depression.
    Albrecht K; Droll H; Giesler JM; Nashan D; Meiss F; Reuter K
    Psychooncology; 2013 Sep; 22(9):1972-8. PubMed ID: 23288588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum levels of soluble intercellular adhesion molecule 1 in malignant lymphoproliferative disorders].
    Li D; Li G; Cui W
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):232-4. PubMed ID: 11601209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.
    Capuron L; Raison CL; Musselman DL; Lawson DH; Nemeroff CB; Miller AH
    Am J Psychiatry; 2003 Jul; 160(7):1342-5. PubMed ID: 12832253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sarcoidosis, myasthenia gravis and anterior ischaemic optic neuropathy: severe side effects of adjuvant interferon-alpha-therapy in malignant melanoma?].
    Kreutzer K; Bonnekoh B; Franke I; Ulrich J; Gollnick H
    J Dtsch Dermatol Ges; 2004 Aug; 2(8):689-94. PubMed ID: 16279234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of plasma concentration of adhesion molecules in late-life depression.
    Dimopoulos N; Piperi C; Salonicioti A; Mitsonis C; Liappas I; Lea RW; Kalofoutis A
    Int J Geriatr Psychiatry; 2006 Oct; 21(10):965-71. PubMed ID: 16927406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
    Arici M; Kahraman S; Gençtoy G; Altun B; Kalyoncu U; Oto A; Kirazli S; Erdem Y; Yasavul U; Turgan C
    Nephrol Dial Transplant; 2006 Apr; 21(4):999-1005. PubMed ID: 16326734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha.
    Tchinda VH; Tadem AD; Tako EA; Tene G; Fogako J; Nyonglema P; Sama G; Zhou A; Leke RG
    Acta Trop; 2007 Apr; 102(1):20-8. PubMed ID: 17397790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of malignant melanoma: disease progression correlated with serum levels of 5-S-Cysteinyldopa (5-S-CD) and intercellular adhesion molecule-1 (ICAM-1).
    Ye Z; Kageshita T; Ishihara T; Ito S; Ono T
    J Dermatol; 1995 May; 22(5):370-5. PubMed ID: 7673560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.